Wonfar 200 Tablet contains Faropenem 200 mg, a broad-spectrum oral beta-lactam antibiotic belonging to the penem class. It exhibits potent bactericidal activity against a wide range of Gram-positive and Gram-negative aerobic and anaerobic pathogens by inhibiting bacterial cell wall synthesis. Faropenem is commonly prescribed for the treatment of respiratory tract infections, urinary tract infections, skin and soft tissue infections, and other bacterial infections caused by susceptible organisms. The drug demonstrates stability against many beta-lactamases, enhancing its efficacy in resistant bacterial strains. Wonfar 200 Tablet is typically administered orally, with dosage and duration determined based on the severity and type of infection, as well as patient-specific factors such as age and renal function. Adverse effects are generally mild and may include gastrointestinal disturbances such as nausea, diarrhea, and abdominal discomfort. Hypersensitivity reactions, though rare, should be monitored closely, especially in patients with a history of beta-lactam allergy. Caution is advised in patients with renal impairment, and dose adjustments may be necessary. Faropenem should be used judiciously to minimize the development of antibiotic resistance. It is contraindicated in individuals with known hypersensitivity to Faropenem or other beta-lactam antibiotics.